Other
Climbing
Climbing is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Exercise in Anxiety and Posttraumatic Stress Disorders
NCT03758599
completednot_applicable
Sport Climbing With Parkinson's Disease
NCT04569981
unknownnot_applicable
The KOMOtini BONE Study: Evaluation of the Osteogenic Potential of Sports
NCT03201302
completednot_applicable
Suspension Syndrome
NCT02726776
Clinical Trials (4)
Showing 4 of 4 trials
NCT03758599Not Applicable
Exercise in Anxiety and Posttraumatic Stress Disorders
NCT04569981Not Applicable
Sport Climbing With Parkinson's Disease
NCT03201302Not Applicable
The KOMOtini BONE Study: Evaluation of the Osteogenic Potential of Sports
NCT02726776Not Applicable
Suspension Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4